This test quantitatively measures the S100A7 biomarker in biopsy tissues of patients at risk of oral cancer in conjunction with the StraticyteTM proprietary algorithms, advanced imaging, and digital pathology. This evidence concerns the gene S100A7 and lip and oral cavity carcinoma.